Program Code: SCF-DBI-PCICU-CHD-0001
Operational Window: Birth → Surgical Palliation/Repair → Longitudinal Recovery
Primary Objective: Preserve circulatory intelligence, optimize oxygen delivery, prevent neurodevelopmental injury, preserve endothelial resilience, and maximize long-term adaptation in children with congenital heart disease.
SECTION 4.1
CLINICAL POSITIONING
Traditional CHD Critical Care Model
Focuses on:
Anatomy
Oxygen saturation
Hemodynamics
Surgical repair
Survival
SCF-DBI CHD Model
Congenital heart disease is viewed as:
Developmental Circulatory Intelligence Disorder
affecting:
Brain development
Endothelial adaptation
Growth biology
Metabolic adaptation
Immune development
Recovery intelligence
Core Principle
Successful CHD management requires preservation of developmental biology throughout the lifespan.
SECTION 4.2
CONGENITAL HEART DISEASE CLASSIFICATION
Category I
Simple Lesions
Examples:
ASD
VSD
PDA
Mild valve disease
Category II
Moderately Complex Lesions
Examples:
Tetralogy of Fallot
Coarctation
Partial AV Canal
Category III
Complex Biventricular Lesions
Examples:
Transposition of Great Arteries
Truncus Arteriosus
Complete AV Canal
Category IV
Single Ventricle Physiology
Examples:
HLHS
Tricuspid Atresia
Double Inlet Left Ventricle
Unbalanced AV Canal
SECTION 4.3
SINGLE VENTRICLE PHYSIOLOGY PROGRAM
Clinical Positioning
Single ventricle circulation is viewed as:
Adaptive Circulatory Intelligence Architecture
requiring continuous balance between:
Pulmonary flow
Systemic flow
Oxygen delivery
Organ perfusion
Strategic Objective
Maintain circulatory equilibrium.
Core Threats
Pulmonary overcirculation
Systemic hypoperfusion
Coronary insufficiency
End-organ injury
Neurodevelopmental impairment
SECTION 4.4
NORWOOD–GLENN–FONTAN CRITICAL CARE PATHWAY
Stage I
Norwood Physiology
Objective:
Preserve systemic output
Maintain coronary perfusion
Maintain cerebral perfusion
Stage II
Bidirectional Glenn
Objective:
Optimize passive pulmonary flow
Reduce ventricular workload
Preserve growth
Stage III
Fontan Circulation
Objective:
Optimize venous return
Preserve end-organ function
Preserve long-term adaptation
SECTION 4.5
PARALLEL VS SERIES CIRCULATION INTELLIGENCE FRAMEWORK
Series Circulation
Normal Physiology
Characteristics:
Independent pulmonary circulation
Independent systemic circulation
Stable oxygen delivery
Parallel Circulation
Norwood Physiology
Characteristics:
Shared ventricular output
Competitive pulmonary/systemic flow
Dynamic oxygen delivery
SCF Principle
Management focuses on:
Flow balance
rather than
Oxygen saturation alone
SECTION 4.6
QP/QS ADAPTATION FRAMEWORK
Purpose
Optimize balance between:
Pulmonary blood flow (Qp)
and
Systemic blood flow (Qs)
Overcirculation Indicators
High oxygen saturation
Rising lactate
Poor systemic perfusion
Low systemic output
Under-Circulation Indicators
Severe hypoxemia
Reduced pulmonary flow
Elevated pulmonary resistance
Monitoring Variables
Lactate
NIRS
Perfusion
Echocardiography
ANMS
SECTION 4.7
RHENOVA SINGLE VENTRICLE PRESERVATION BUNDLE
Strategic Objective
Preserve adaptation through staged palliation.
Bundle Components
Neurodevelopment Protection
Monitor:
CAI
Cerebral NIRS
Developmental trajectory
Endothelial Protection
Monitor:
EII
Perfusion
Glycocalyx integrity
Growth Preservation
Monitor:
Weight gain
Nutritional adaptation
MAS
Recovery Preservation
Monitor:
Functional status
Recovery trajectory
SECTION 4.8
CONGENITAL HEART DISEASE SURVEILLANCE PLATFORM
Domain A
Neurocardiac Intelligence
Monitor:
Ventricular performance
Cardiac output
Oxygen delivery
Domain B
Neurovascular Intelligence
Monitor:
Perfusion
EII
Tissue oxygenation
Domain C
Neurodevelopmental Intelligence
Monitor:
CAI
Developmental milestones
Cognitive progression
Domain D
Recovery Intelligence
Monitor:
Growth
Rehabilitation
Functional adaptation
SECTION 4.9
INTERSTAGE SURVEILLANCE PROGRAM
High-Risk Population
Between:
Norwood → Glenn
and
Glenn → Fontan
Monitoring Variables
Weight gain
Oxygen saturation
Feeding tolerance
Lactate
Perfusion
ANMS
Escalation Triggers
Poor growth
Feeding failure
Increasing cyanosis
ANMS decline >15%
SECTION 4.10
PULMONARY HYPERTENSION IN CHD FRAMEWORK
Clinical Positioning
Pulmonary hypertension represents:
Pulmonary-Circulatory Adaptation Failure
Core Monitoring
Pulmonary pressures
RV function
Oxygen delivery
NIRS
EII
Recovery Goals
Preserve pulmonary vascular adaptation
Preserve ventricular function
SECTION 4.11
RHENOVA CHD RECOVERY INTELLIGENCE PLATFORM
Recovery Domains
Cardiac recovery
Endothelial recovery
Neurodevelopmental recovery
Growth recovery
Functional recovery
Longitudinal Objectives
School readiness
Physical activity participation
Cognitive development
Social adaptation
SECTION 4.12
CHD ANMS FRAMEWORK
Neuroimmune Domain
Monitor:
Surgical inflammation
Infection burden
Neurocardiac Domain
Monitor:
Ventricular performance
Oxygen delivery
Neurovascular Domain
Monitor:
EII
Perfusion
Neurometabolic Domain
Monitor:
Growth
MAS
Nutritional adaptation
Neuroendocrine Domain
Monitor:
Recovery reserve
Developmental adaptation
SECTION 4.13
CHD ESCALATION MATRIX
Level 1
Enhanced Monitoring
Triggers:
Feeding intolerance
Growth slowing
Level 2
Focused Intervention
Triggers:
Lactate elevation
Perfusion decline
NIRS decline
Level 3
Multidisciplinary Escalation
Triggers:
Ventricular dysfunction
Progressive cyanosis
EII decline >20%
Level 4
Critical Rescue Activation
Triggers:
ANMS <40
Severe circulatory imbalance
Progressive organ dysfunction
SECTION 4.14
LONGITUDINAL RECOVERY PROGRAM
Monitoring Windows
Discharge
↓
30 Days
↓
90 Days
↓
6 Months
↓
12 Months
↓
Annual Surveillance
Recovery Domains
Growth
Neurodevelopment
Exercise tolerance
Cognitive development
Functional adaptation
SECTION 4.15
CHD RECOVERY ENDPOINTS
Clinical
Stable circulation
Stable growth
Reduced hospitalization
Functional
Age-appropriate development
Physical participation
Educational readiness
Biological Intelligence
ANMS >80
NCRS >80
EII >80
CAI >80
Positive developmental trajectory
PAGE 4 COMPLETION
Next Page (Page 5):